Phil’s $25M Series B Financing

Fenwick & West represented Phil Inc. in the transaction.

Phil Inc. is an end-to-end technology platform for distributing and managing specialty prescription drugs. Through it’s platform that connects patients, prescribers, pharmacies and manufacturers, they lower systemic cost, improve patient outcomes and allow prescribers and pharmacies to focus on patient care.

The financing round was led by new investor GreatPoint Ventures, with support from Tarsadia Investments, Crosslink Capital and Uncork Capital.??????

The funding will fuel company growth, with a focus on hiring technical talent and expanding geographic footprint.

Fenwick represented Phil with a team led by corporate lawyers Michael Esquivel (Picture), Stefano Quintini, Malcom Katz, Kyle Canchola and Benjamin Toussant.??????

Involved fees earner: Kyle Canchola – Fenwick & West LLP; Michael Esquivel – Fenwick & West LLP; Malcolm Katz – Fenwick & West LLP; Stefano Quintini – Fenwick & West LLP; Benjamin Toussant – Fenwick & West LLP;

Law Firms: Fenwick & West LLP;

Clients: Phil Inc.;


Author: Ambrogio Visconti